181 related articles for article (PubMed ID: 21256175)
1. Arginine-vasopressin V1a receptor inhibition improves neurologic outcomes following an intracerebral hemorrhagic brain injury.
Manaenko A; Fathali N; Khatibi NH; Lekic T; Hasegawa Y; Martin R; Tang J; Zhang JH
Neurochem Int; 2011 Mar; 58(4):542-8. PubMed ID: 21256175
[TBL] [Abstract][Full Text] [Related]
2. Post-treatment with SR49059 improves outcomes following an intracerebral hemorrhagic stroke in mice.
Manaenko A; Fathali N; Khatibi NH; Lekic T; Shum KJ; Martin R; Zhang JH; Tang J
Acta Neurochir Suppl; 2011; 111():191-6. PubMed ID: 21725754
[TBL] [Abstract][Full Text] [Related]
3. NC1900, an arginine vasopressin analogue, fails to reduce brain edema and improve neurobehavioral deficits in an intracerebral hemorrhagic stroke mice model.
Manaenko A; Lekic T; Zhang JH; Tang J
Acta Neurochir Suppl; 2011; 111():155-9. PubMed ID: 21725748
[TBL] [Abstract][Full Text] [Related]
4. Selective vasopressin-1a receptor antagonist prevents brain edema, reduces astrocytic cell swelling and GFAP, V1aR and AQP4 expression after focal traumatic brain injury.
Marmarou CR; Liang X; Abidi NH; Parveen S; Taya K; Henderson SC; Young HF; Filippidis AS; Baumgarten CM
Brain Res; 2014 Sep; 1581():89-102. PubMed ID: 24933327
[TBL] [Abstract][Full Text] [Related]
5. The modulation of aquaporin-4 by using PKC-activator (phorbol myristate acetate) and V1a receptor antagonist (SR49059) following middle cerebral artery occlusion/reperfusion in the rat.
Okuno K; Taya K; Marmarou CR; Ozisik P; Fazzina G; Kleindienst A; Gulsen S; Marmarou A
Acta Neurochir Suppl; 2008; 102():431-6. PubMed ID: 19388361
[TBL] [Abstract][Full Text] [Related]
6. The role of vasopressin V1A receptors in cytotoxic brain edema formation following brain injury.
Kleindienst A; Dunbar JG; Glisson R; Marmarou A
Acta Neurochir (Wien); 2013 Jan; 155(1):151-64. PubMed ID: 23188468
[TBL] [Abstract][Full Text] [Related]
7. Modulation of AQP4 expression by the selective V1a receptor antagonist, SR49059, decreases trauma-induced brain edema.
Taya K; Gulsen S; Okuno K; Prieto R; Marmarou CR; Marmarou A
Acta Neurochir Suppl; 2008; 102():425-9. PubMed ID: 19388360
[TBL] [Abstract][Full Text] [Related]
8. Arginine-vasopressin V1 but not V2 receptor antagonism modulates infarct volume, brain water content, and aquaporin-4 expression following experimental stroke.
Liu X; Nakayama S; Amiry-Moghaddam M; Ottersen OP; Bhardwaj A
Neurocrit Care; 2010 Feb; 12(1):124-31. PubMed ID: 19806476
[TBL] [Abstract][Full Text] [Related]
9. Effect of small molecule vasopressin V1a and V2 receptor antagonists on brain edema formation and secondary brain damage following traumatic brain injury in mice.
Krieg SM; Sonanini S; Plesnila N; Trabold R
J Neurotrauma; 2015 Feb; 32(4):221-7. PubMed ID: 25111427
[TBL] [Abstract][Full Text] [Related]
10. Real-time monitoring of changes in brain extracellular sodium and potassium concentrations and intracranial pressure after selective vasopressin-1a receptor inhibition following focal traumatic brain injury in rats.
Filippidis AS; Liang X; Wang W; Parveen S; Baumgarten CM; Marmarou CR
J Neurotrauma; 2014 Jul; 31(14):1258-67. PubMed ID: 24635833
[TBL] [Abstract][Full Text] [Related]
11. Role of vasopressin V(1a) and V2 receptors for the development of secondary brain damage after traumatic brain injury in mice.
Trabold R; Krieg S; Schöller K; Plesnila N
J Neurotrauma; 2008 Dec; 25(12):1459-65. PubMed ID: 19118456
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of the V1a receptor antagonist SR49059 on brain edema formation following middle cerebral artery occlusion in the rat.
Kleindienst A; Fazzina G; Dunbar JG; Glisson R; Marmarou A
Acta Neurochir Suppl; 2006; 96():303-6. PubMed ID: 16671476
[TBL] [Abstract][Full Text] [Related]
13. Carvacrol alleviates cerebral edema by modulating AQP4 expression after intracerebral hemorrhage in mice.
Zhong Z; Wang B; Dai M; Sun Y; Sun Q; Yang G; Bian L
Neurosci Lett; 2013 Oct; 555():24-9. PubMed ID: 24051341
[TBL] [Abstract][Full Text] [Related]
14. Conivaptan, a Selective Arginine Vasopressin V1a and V2 Receptor Antagonist Attenuates Global Cerebral Edema Following Experimental Cardiac Arrest via Perivascular Pool of Aquaporin-4.
Nakayama S; Amiry-Moghaddam M; Ottersen OP; Bhardwaj A
Neurocrit Care; 2016 Apr; 24(2):273-82. PubMed ID: 26732270
[TBL] [Abstract][Full Text] [Related]
15. Safety, tolerability, and pharmacokinetics of SR 49059, a V1a vasopressin receptor antagonist, after repeated oral administration in healthy volunteers.
Brouard R; Laporte V; Serradeil Le Gal C; Pignol R; Jang H; Donat F; Lockwood G; Fournie D; Dreux F
Adv Exp Med Biol; 1998; 449():455-65. PubMed ID: 10026839
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of lysophosphatidic acid receptor 1 relieves PMN recruitment in CNS via LPA1/TSP1/CXCR2 pathway and alleviates disruption on blood-brain barrier following intracerebral haemorrhage in mice.
Gao L; Peng L; Sherchan P; Tang H; Liu Y; Xiao J; Shi H; Luo Y; Tang J; Zhang JH; Xia Y
Fluids Barriers CNS; 2023 May; 20(1):33. PubMed ID: 37165450
[TBL] [Abstract][Full Text] [Related]
17. Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands.
Serradeil-Le Gal C; Wagnon J; Valette G; Garcia G; Pascal M; Maffrand JP; Le Fur G
Prog Brain Res; 2002; 139():197-210. PubMed ID: 12436936
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factors preserve blood-brain barrier integrity through RhoA inhibition after intracerebral hemorrhage in mice.
Huang B; Krafft PR; Ma Q; Rolland WB; Caner B; Lekic T; Manaenko A; Le M; Tang J; Zhang JH
Neurobiol Dis; 2012 Apr; 46(1):204-14. PubMed ID: 22300708
[TBL] [Abstract][Full Text] [Related]
19. Small Interfering RNA Targeting DMP1 Protects Mice Against Blood-Brain Barrier Disruption and Brain Injury After Intracerebral Hemorrhage.
Shu Y; Huang J; Gao M; Gan S; Zhu S; Xu S; Yang Z; Liao Y; Lu W
J Stroke Cerebrovasc Dis; 2021 Jun; 30(6):105760. PubMed ID: 33845422
[TBL] [Abstract][Full Text] [Related]
20. Arginine-Vasopressin Receptor Blocker Conivaptan Reduces Brain Edema and Blood-Brain Barrier Disruption after Experimental Stroke in Mice.
Zeynalov E; Jones SM; Seo JW; Snell LD; Elliott JP
PLoS One; 2015; 10(8):e0136121. PubMed ID: 26275173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
